These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20067842)

  • 21. Genetic heterogeneity of the hepatitis C virus.
    Bukh J; Miller RH; Purcell RH
    Princess Takamatsu Symp; 1995; 25():75-91. PubMed ID: 8875612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes.
    Hnatyszyn HJ
    Antivir Ther; 2005; 10(1):1-11. PubMed ID: 15751759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.
    Blaising J; Pécheur EI
    Biochimie; 2013 Jan; 95(1):96-102. PubMed ID: 22884392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Overview of hepatitis C virus from its discovery to now].
    Inoue K; Yoshiba M
    Rinsho Byori; 2001 Aug; 49(8):733-40. PubMed ID: 11573279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum lipid pattern in chronic hepatitis C: histological and virological correlations.
    Siagris D; Christofidou M; Theocharis GJ; Pagoni N; Papadimitriou C; Lekkou A; Thomopoulos K; Starakis I; Tsamandas AC; Labropoulou-Karatza C
    J Viral Hepat; 2006 Jan; 13(1):56-61. PubMed ID: 16364083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches.
    von Hahn T; Steinmann E; Ciesek S; Pietschmann T
    Expert Rev Gastroenterol Hepatol; 2010 Feb; 4(1):63-79. PubMed ID: 20136590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication.
    Sagan SM; Rouleau Y; Leggiadro C; Supekova L; Schultz PG; Su AI; Pezacki JP
    Biochem Cell Biol; 2006 Feb; 84(1):67-79. PubMed ID: 16462891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein.
    Sato S; Fukasawa M; Yamakawa Y; Natsume T; Suzuki T; Shoji I; Aizaki H; Miyamura T; Nishijima M
    J Biochem; 2006 May; 139(5):921-30. PubMed ID: 16751600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Optimal antiviral therapy of chronic hepatitis caused by hepatitis C virus].
    Cooreman MP; Stadhouders P
    Orv Hetil; 1997 Jun; 138(22 Suppl 1):1476-82. PubMed ID: 9221377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus genetic variability in patients undergoing antiviral therapy.
    Cristina J; del Pilar Moreno M; Moratorio G
    Virus Res; 2007 Aug; 127(2):185-94. PubMed ID: 17449128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.
    Ballardini G; Groff P; Pontisso P; Giostra F; Francesconi R; Lenzi M; Zauli D; Alberti A; Bianchi FB
    J Clin Invest; 1995 May; 95(5):2067-75. PubMed ID: 7738174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hepatitis C virus life cycle as a target for new antiviral therapies.
    Pawlotsky JM; Chevaliez S; McHutchison JG
    Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver].
    Hige S
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data.
    Negro F; Sanyal AJ
    Liver Int; 2009 Mar; 29 Suppl 2():26-37. PubMed ID: 19187070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assembly of hepatitis C virus particles.
    Suzuki T
    Microbiol Immunol; 2011 Jan; 55(1):12-8. PubMed ID: 21175769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virology and cell biology of the hepatitis C virus life cycle: an update.
    Dubuisson J; Cosset FL
    J Hepatol; 2014 Nov; 61(1 Suppl):S3-S13. PubMed ID: 25443344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interplay between hepatitis C virus and lipid metabolism during virus entry and assembly.
    Lavie M; Dubuisson J
    Biochimie; 2017 Oct; 141():62-69. PubMed ID: 28630011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.